linsidomine has been researched along with Optic Nerve Diseases in 1 studies
linsidomine: RN given refers to parent cpd; structure
Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, S | 1 |
| Rogers, P | 1 |
| Krishnamoorthy, RR | 1 |
| Stankowska, DL | 1 |
| Dias, HV | 1 |
| Yorio, T | 1 |
1 other study available for linsidomine and Optic Nerve Diseases
| Article | Year |
|---|---|
Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy.
Topics: Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Glaucoma; Humans; Hydrogen | 2016 |